Results 161 to 170 of about 22,537 (257)

Florzolotau (18F) retention is linked to neuropsychological performance in tauopathy. [PDF]

Alzheimers Dement
Shimizu A, Iwabuchi Y, Bun S, Watanabe M, Kubota M, Shimohama S, Tezuka T, Takahata K, Tabuchi H, Seki M, Momota Y, Yamamoto Y, Shikimoto R, Mimura Y, Kurose S, Sakurai R, Takayama T, Hoshino Y, Hoshino T, Suzuki N, Morimoto A, Osumi A, Mimura M, Jinzaki M, Ito D.   +24 more
europepmc   +1 more source

Understanding the Phenotypic Heterogeneity Within the Sporadic Creutzfeldt–Jakob Disease MV1 Subtype

Neuropathology and Applied Neurobiology, Volume 52, Issue 3, June 2026.
We present the clinical, pathological and prion biophysical features of three atypical cases of the MV1 subtype of sporadic Creutzfeldt–Jakob disease (sCJD). We propose that these heterozygous cases exist on a spectrum ranging from MM1‐like to VV1‐like phenotypes and recommend that subtyping be performed at pH 6.9 to avoid missing atypical or mixed ...
Satish K. Nemani, Leonardo M. Cortez, Jennifer Myskiw, Ignazio Cali, Stephanie A. Booth, Gerard H. Jansen, Valerie L. Sim   +6 more
wiley   +1 more source

The Genotoxic Stress Sensor ZBP1 Drives Tau Pathology. [PDF]

Cells
Thanos JM, Campbell OC, Natale NR, Royo Marco A, Puchalski MA, Lukens JR.   +5 more
europepmc   +1 more source

Brainstem pathology in anti-IgLON5 disease: new insights into early events and tau progression. [PDF]

Brain
Reinecke R, Nitsch S, Faber F, Elmas C, Gaubinger M, Simonovska Serra A, Endmayr V, Koneczny I, Berger-Sieczkowski E, Blaabjerg M, Erro ME, Ferrari J, Glatzel M, Heidbreder A, Högl B, Jansen C, Lewerenz J, Moser P, Myllykangas L, Krogh Petersen J, Schnider P, Stefani A, Titulaer MJ, Yilmazer-Hanke D, Weis S, Sabater L, Gaig C, Gelpi E, Höftberger R.   +28 more
europepmc   +1 more source

Tau PET and tauopathies [PDF]

European Journal of Nuclear Medicine and Molecular Imaging, 2016
openaire   +3 more sources

Clinicoanatomic localization of iron-rich gliosis in aphasic presentations of globular glial tauopathy. [PDF]

Brain Commun
Irwin DJ, Emrani S, Ohm DT, Trotman W, Bahena A, Teunissen-Bermeo E, Sabatini P, Das SR, Mizsei G, Prabhakaran K, Ittyerah R, Coslett HB, Massimo L, Wolk DA, Detre JA, Gee JC, Lee EB, Yushkevich P, McMillan CT, Tisdall MD.   +19 more
europepmc   +1 more source

A critical appraisal of the link between apolipoprotein E and Tau. [PDF]

Curr Opin Neurol
Das S, Hyman BT, Serrano-Pozo A.
europepmc   +1 more source

Defining patient-centered amyloid PET thresholds for the onset of tauopathy in Alzheimer's disease. [PDF]

Alzheimers Dement
Zhu Z, Steward A, Dehsarvi A, Roemer-Cassiano SN, Dewenter A, Biel D, Hirsch F, Frontzkowski L, Pescoller J, Klonowski M, Gnörich J, Pontecorvo MJ, Shcherbinin S, Schöll M, Buckley R, Ossenkoppele R, Xie F, Guo T, Alzheimer's Disease Neuroimaging Initiative, Höglinger G, Brendel M, Franzmeier N.   +21 more
europepmc   +1 more source

Sex differences for clinical presentations and co-pathologies in four-repeat tauopathies. [PDF]

Biol Sex Differ
Bayram E, Carter DJ, Aslam S, Forbes E, Holden SK.   +4 more
europepmc   +1 more source

PART as a Negative Outcome Modifier of Glioblastoma Treatment, Case Report. [PDF]

NeuroSci
Terada R, Dailey J, Yan S, Punsoni M, Wong ET.   +4 more
europepmc   +1 more source